ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2387

The Effect of Arthroscopic Partial Meniscectomy in Patients with Osteoarthritis on Meniscal Body Extrusion

Martin Englund1,2, Fan Zhang3, Ali Guermazi4, Frank W Roemer5,6, Elena Losina7 and Jeffrey N. Katz8, 1Clinical Epidemiology Unit, Orthopedics, Dept of Clinical Sciences Lund, Lund University, Lund, Sweden, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopedics, Clinical Sciences Lund, Lund University, Lund, Sweden, 4Boston University School of Medicine, Boston, MA, 5Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany, 6Department of Radiology, Boston University School of Medicine, Boston, MA, 7Orthopaedics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthroscopy, Magnetic resonance imaging (MRI), meniscectomy, meniscus and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Meniscal damage and extrusion are both strongly associated with the progression of knee OA. Concerns have recently been raised that arthroscopic partial meniscectomy (APM) may accelerate OA development. It is currently unclear whether performing APM or leaving a meniscal tear in situ affect meniscus position differently. Thus we determined the effect of APM on medial meniscal body extrusion in patients with OA and meniscal tear.

Methods: Post-hoc analysis using data from the MeTeOR trial (ClinicalTrials.gov number, NCT00597012), a multi-center randomized controlled trial that involved patients aged 45 or older with knee symptoms and meniscal tear as well as osteoarthritic changes detected on MRI (cartilage lesions) or radiography. Patients were randomized to either APM coupled with postoperative physical therapy (PT) or a standardized PT regime. Cross-over from PT to APM due to treatment failure was allowed. One orthopedic surgeon, who was blinded to treatment allocation, actual treatment received, and patient characteristics, but who had knowledge of the time sequence, performed paired meniscal measures on the baseline and 18-month mid-coronal 1.5T knee MR images. The observer measured medial meniscal body extrusion to the closest 0.1 mm using Sante DICOM Editor software. Intra-observer reliability (intra-class correlation coefficient) was 0.85 (95% CI: 0.73-0.92). We defined our primary outcome as the absolute change in mm of the position of the external medial meniscal body margin from baseline to the 18-month exam. We used the intention-to-treat (ITT) principle for the primary analysis, and we also performed a secondary as-treated analysis, i.e., taking into account the cross over after randomization (including those who crossed over from PT to APM into the APM group).

Results: The MeTeOR trial patients have mean (SD) age 59 (7.9) years at baseline and 56% were women. In this analysis we included the first 223 patients who had both baseline and 18-month follow-up knee MRIs available and readable. Of these, 108 patients were randomized to APM and 115 to standardized PT. The mean medial meniscus body extrusion at the baseline exam was similar; mean (SD) 3.2 (1.4) mm in the APM arm vs. 3.4 (1.5) mm in the physical therapy arm (p=0.34). We found no statistically significant difference in the change of extrusion of the medial meniscal body in the ITT analysis; mean (SD) change +0.47 mm (1.6) in the APM arm vs +0.40 (1.6) mm in the PT arm (p=0.72). In the PT arm, 42 patients (36.5%) crossed over to surgery during the 18 months of follow-up, and 4 patients (3.7%) randomized to APM never had the surgery. We did not find statistically significant differences in the corresponding as-treated analysis, mean (SD) change +0.36 mm (1.5) in those having APM (n=146) vs +0.58 (1.8) mm in those patients having PT only (n=77) (p=0.32).

Conclusion: We observed on average small changes in medial meniscal body extrusion over 18 months in MeTeOR trial participants. APM of a meniscal tear in patients with knee OA does not lead to increased meniscal body extrusion as compared to non-operative management.


Disclosure: M. Englund, None; F. Zhang, None; A. Guermazi, Boston Imaging Core Lab, LLC, 1,TissueGene, 5,OrthoTrophix, 5,MerckSerono, 5,Genzyme Corporation, 5; F. W. Roemer, Boston Imaging Core Lab, 1; E. Losina, None; J. N. Katz, None.

To cite this abstract in AMA style:

Englund M, Zhang F, Guermazi A, Roemer FW, Losina E, Katz JN. The Effect of Arthroscopic Partial Meniscectomy in Patients with Osteoarthritis on Meniscal Body Extrusion [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-arthroscopic-partial-meniscectomy-in-patients-with-osteoarthritis-on-meniscal-body-extrusion/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-arthroscopic-partial-meniscectomy-in-patients-with-osteoarthritis-on-meniscal-body-extrusion/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology